Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | MGLL | Q99685 | 4/20 | 0.46 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | SLC18A3 | Q16572 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | PHGDH | O43175 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13157849 | 1.00 | KMT2A (0.52) | KMT2AMEN1MGLLHSD11B1HSP90AA1 | |
| SCHEMBL3098323 | 1.00 | KMT2A (0.52) | KMT2AMEN1MGLLHSD11B1HSP90AA1 | |
| SCHEMBL13157952 | 1.00 | KMT2A (0.52) | KMT2AMEN1MGLLHSD11B1HSP90AA1 | |
| SCHEMBL3104941 | 0.93 | MGLL (0.45) | KMT2AMEN1MGLLHSD11B1HSP90AA1 | |
| SCHEMBL13157762 | 0.93 | MGLL (0.45) | KMT2AMEN1MGLLHSD11B1HSP90AA1 | |
| SCHEMBL3107797 | 0.92 | MGLL (0.46) | KMT2AMEN1MGLLHSD11B1HSP90AA1 | |
| SCHEMBL13157845 | 0.92 | MGLL (0.46) | KMT2AMEN1MGLLHSD11B1HSP90AA1 | |
| SCHEMBL3107734 | 0.92 | HSP90AA1 (0.45) | KMT2AMEN1MGLLHSD11B1HSP90AA1 | |
| SCHEMBL13157853 | 0.92 | HSP90AA1 (0.45) | KMT2AMEN1MGLLHSD11B1HSP90AA1 | |
| SCHEMBL3097700 | 0.91 | MGLL (0.45) | KMT2AMEN1MGLLHSD11B1HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8399455-B2 | Compounds useful as chemokine receptor antagonists | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2013-03-19 | — | — | US | disclosed |
| US-20100234356-A1 | COMPOUNDS USEFUL AS CHEMOKINE RECEPTOR ANTAGONISTS | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2010-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100234356-A1 | COMPOUNDS USEFUL AS CHEMOKINE RECEPTOR ANTAGONISTS | ACKR3, CCR5, CXCR2 | KMT2A 4425/4885MEN1 2336/4885MGLL 2345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.